Improvement of diabetes after treatment with somatostatin analogue SMS 201-995 in an acromegalic patient

L. Cantalamessa, A. Catania, M. Baldini, A. Orsatti

Research output: Contribution to journalArticle

Abstract

The beneficial effects of long acting somatostatin analogue SMS 201-995 in an acromegalic patient affected by severe diabetes mellitus are reported. Neither human insulin alone nor human insulin plus bromocriptine allowed satisfactory metabolic control though, with the latter treatment, virtually normal plasma GH levels were reached. Conversely, addition of SMS 201-995 to insulin treatment led to normalization of blood glucose. This result was obtained with a dose of SMS 201-995 of 400 μg/day and only after 3 weeks of therapy.

Original languageEnglish
Pages (from-to)790-791
Number of pages2
JournalHormone and Metabolic Research
Volume18
Issue number11
Publication statusPublished - 1986

Fingerprint

Octreotide
Medical problems
Somatostatin
Insulin
Bromocriptine
Blood Glucose
Diabetes Mellitus
Therapeutics
Plasmas

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology

Cite this

Improvement of diabetes after treatment with somatostatin analogue SMS 201-995 in an acromegalic patient. / Cantalamessa, L.; Catania, A.; Baldini, M.; Orsatti, A.

In: Hormone and Metabolic Research, Vol. 18, No. 11, 1986, p. 790-791.

Research output: Contribution to journalArticle

@article{c60fc7069e8e4ca69fd7775a8be62001,
title = "Improvement of diabetes after treatment with somatostatin analogue SMS 201-995 in an acromegalic patient",
abstract = "The beneficial effects of long acting somatostatin analogue SMS 201-995 in an acromegalic patient affected by severe diabetes mellitus are reported. Neither human insulin alone nor human insulin plus bromocriptine allowed satisfactory metabolic control though, with the latter treatment, virtually normal plasma GH levels were reached. Conversely, addition of SMS 201-995 to insulin treatment led to normalization of blood glucose. This result was obtained with a dose of SMS 201-995 of 400 μg/day and only after 3 weeks of therapy.",
author = "L. Cantalamessa and A. Catania and M. Baldini and A. Orsatti",
year = "1986",
language = "English",
volume = "18",
pages = "790--791",
journal = "Hormone and Metabolic Research",
issn = "0018-5043",
publisher = "Georg Thieme Verlag",
number = "11",

}

TY - JOUR

T1 - Improvement of diabetes after treatment with somatostatin analogue SMS 201-995 in an acromegalic patient

AU - Cantalamessa, L.

AU - Catania, A.

AU - Baldini, M.

AU - Orsatti, A.

PY - 1986

Y1 - 1986

N2 - The beneficial effects of long acting somatostatin analogue SMS 201-995 in an acromegalic patient affected by severe diabetes mellitus are reported. Neither human insulin alone nor human insulin plus bromocriptine allowed satisfactory metabolic control though, with the latter treatment, virtually normal plasma GH levels were reached. Conversely, addition of SMS 201-995 to insulin treatment led to normalization of blood glucose. This result was obtained with a dose of SMS 201-995 of 400 μg/day and only after 3 weeks of therapy.

AB - The beneficial effects of long acting somatostatin analogue SMS 201-995 in an acromegalic patient affected by severe diabetes mellitus are reported. Neither human insulin alone nor human insulin plus bromocriptine allowed satisfactory metabolic control though, with the latter treatment, virtually normal plasma GH levels were reached. Conversely, addition of SMS 201-995 to insulin treatment led to normalization of blood glucose. This result was obtained with a dose of SMS 201-995 of 400 μg/day and only after 3 weeks of therapy.

UR - http://www.scopus.com/inward/record.url?scp=0023007862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023007862&partnerID=8YFLogxK

M3 - Article

C2 - 2878866

AN - SCOPUS:0023007862

VL - 18

SP - 790

EP - 791

JO - Hormone and Metabolic Research

JF - Hormone and Metabolic Research

SN - 0018-5043

IS - 11

ER -